Article info

PDF

Original research article
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

Authors

  • Thor Ueland Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway KG Jebsen TREC, University of Tromsø, Tromsø, Norway PubMed articlesGoogle scholar articles
  • Ola Kleveland Department of Clinic of Cardiology, St Olavs Hospital, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Annika E Michelsen Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Rune Wiseth Department of Clinic of Cardiology, St Olavs Hospital, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Jan Kristian Damås Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway PubMed articlesGoogle scholar articles
  • Pål Aukrust Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway PubMed articlesGoogle scholar articles
  • Lars Gullestad Institute of Clinical Medicine, University of Oslo, Oslo, Norway Department of Cardiology, Oslo University Hospital Rikshospitalet, Oslo, Norway Center for Heart Failure Research, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Bente Halvorsen Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  • Arne Yndestad Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway Center for Heart Failure Research, University of Oslo, Oslo, Norway PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Thor Ueland; thor.ueland{at}medisin.uio.no
View Full Text

Citation

Ueland T, Kleveland O, Michelsen AE, et al
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction

Publication history

  • Received December 18, 2017
  • Revision received April 6, 2018
  • Accepted May 15, 2018
  • First published September 18, 2018.
Online issue publication 
September 18, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.